Hers just launched a new GLP‑1 weight loss membership starting at $39 for the first month. Here’s how it works, what’s included and how to join.

The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

The Trump administration has secured pricing agreements with major drugmakers to lower GLP-1 weight loss drug costs to ...

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

A UAB-developed automated online weight loss program helps cancer survivors achieve the highest weight loss ever reported for a digital intervention, improving cardiometabolic health, diet quality and ...

Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

Eli Lilly's new daily pill GLP-1 moved through the FDA approval process faster after the FDA's new review and approval process.

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

Weight-loss clinics have opened at a steady pace across upstate New York over the past few years. From Geneva to Canandaigua, more residents are turning to medically supervised programs for help with ...